- Home
- EXC vs CNC Comparison
EXC vs CNC Comparison
Compare EXC & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXC
- CNC
- Stock Information
- Founded
- EXC 1999
- CNC 1984
- Country
- EXC United States
- CNC United States
- Employees
- EXC N/A
- CNC N/A
- Industry
- EXC Power Generation
- CNC Medical Specialities
- Sector
- EXC Utilities
- CNC Health Care
- Exchange
- EXC Nasdaq
- CNC Nasdaq
- Market Cap
- EXC 36.1B
- CNC 29.0B
- IPO Year
- EXC N/A
- CNC 2001
- Fundamental
- Price
- EXC $38.73
- CNC $59.09
- Analyst Decision
- EXC Buy
- CNC Buy
- Analyst Count
- EXC 15
- CNC 13
- Target Price
- EXC $41.08
- CNC $83.92
- AVG Volume (30 Days)
- EXC 6.4M
- CNC 7.0M
- Earning Date
- EXC 10-30-2024
- CNC 10-25-2024
- Dividend Yield
- EXC 3.93%
- CNC N/A
- EPS Growth
- EXC 12.91
- CNC 29.81
- EPS
- EXC 2.43
- CNC 5.75
- Revenue
- EXC $22,924,000,000.00
- CNC $146,204,000,000.00
- Revenue This Year
- EXC $1.72
- CNC N/A
- Revenue Next Year
- EXC $3.26
- CNC $2.68
- P/E Ratio
- EXC $15.94
- CNC $10.28
- Revenue Growth
- EXC 9.03
- CNC 4.91
- 52 Week Low
- EXC $33.35
- CNC $57.20
- 52 Week High
- EXC $41.43
- CNC $81.42
- Technical
- Relative Strength Index (RSI)
- EXC 45.96
- CNC 39.93
- Support Level
- EXC $37.81
- CNC $57.20
- Resistance Level
- EXC $39.39
- CNC $59.86
- Average True Range (ATR)
- EXC 0.69
- CNC 1.87
- MACD
- EXC 0.08
- CNC 0.09
- Stochastic Oscillator
- EXC 53.01
- CNC 23.05
About EXC Exelon Corporation
Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.C.
About CNC Centene Corporation
Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.